Winner of the 2021 Young Investigator Award

Dr Giacomo Boffa receives the 2021 Young Investigator Award on his project on using aHSCT in individuals with secondary progressive MS

Answering questions on progressive MS treatment and research

Watch the International Progressive MS Alliance webcast

FDA backs further research into ‘neurofilament light chain’

The regulatory agency’s Letter of Support will stimulate more studies that advance development and validation of the biomarker ‘neurofilament light chain’

Professor Alan Thompson wins the prestigious MS Charcot Award

Professor Thompson wins the 2021 lifetime achievement award for outstanding research into the understanding and treatment of MS

Alliance funds 19 Research Challenge Awards looking for answers on progression

In time for World MS Day, €1,425,000 has been awarded to help identify new therapeutic targets in progressive MS

Catch up on the latest breakthroughs in progressive MS treatments

A first-of-its-kind global research network funded by the International Progressive MS Alliance aims to develop new, effective treatments for progressive MS.

Research on fighting MS brain inflammation with information from the gut

This paper was first published in Nature January 2021

Progressive MS and accelerating breakthough treatments

Global webcast on 4 March

How do we accelerate life-changing treatments for people with progressive MS?

Join the discussion about research breakthroughs that could accelerate new treatments for people with progressive MS

A potential biomarker for progressive MS

The use of neurofilament light chain (NfL) as a biomarker could revolutionise clinical trials in progressive MS.

Global webcast on fatigue in progressive MS

Register below for the global webcast on fatigue research and treatment

Super-charging mitochondria – a potential pathway to treat progressive MS

New research funded by the International Progressive MS Alliance looks at ways that nerve fibres protect themselves from damage.

Answering today’s big questions in progressive MS

Watch the International Progressive MS Alliance webcast here

Discovering life-changing treatments for progressive MS

An International Progressive MS Alliance global webcast

Let’s talk about symptoms and well-being in progressive MS

Register for the Progressive MS Alliance's Facebook Live event on symptom management and well-being in progressive MS

Join the discussion on symptom management & well-being in progressive MS

Register for the Progressive MS Alliance's Facebook Live event

Challenges in Progressive MS Awards: taking risks to reap rewards

Progressive MS Awards

First MS organisation in Latin America joins the Progressive MS Alliance

The International Progressive MS Alliance is growing!

Global webcast on solving progressive MS: progress achieved and hope for the future

Results released from first multi-drug clinical trial in MS

The results of the MS-SMART trial, an innovative trial testing multiple drugs at the same time, have ruled out three repurposed drugs for the treatment of progressive MS.

Blocking blood protein could protect nerves in MS

A treatment that blocks a type of protein that accumulates in the brain was able to reduce inflammation and damage to nerves in laboratory models of MS.

Making a difference through rehab research at the Progressive MS Alliance Conference

Researchers, clinicians and people living with MS, from around the world converged on the city of Toronto in Canada for the 3rd Congress of the International Progressive MS Alliance.

MS International Federation’s members gather in London to mark 50 years of the global MSIF movement

More than 100 staff, volunteers, and people with and affected by MS from 39 countries gathered in London in September for the MSIF Movement’s 50th Anniversary meetings.

Alliance holds pivotal London meeting

A meeting of minds took place at the recent International Progressive MS Alliance event in London

Celebrating the role of new technologies in transforming the lives of people affected by MS

Matthew Miles, Chief Executive of MS Research Australia, shared insights on how technology is revolutionising research, treatment, diagnosis, and more